Clinical trial
Haploidentical Stem Cell Transplant for Treatment Refractory Hematological…
NCT00145613 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00145613 |
|---|---|
| Title | Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies |
| Official title | Haploidentical Stem Cell Transplantation Utilizing T-Cell Depletion as Therapy for Patients With Refractory Hematological Malignancies |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Secondary AML, Myelodysplastic Syndrome (MDS), Secondary MDS, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia (JMML), Paroxysmal Nocturnal Hemoglobinuria (PNH), Lymphoma, Non-Hodgkin and 1 more |
| Intervention type | Device, Drug, Procedure |
| Interventions | Stem Cell Transplantation, Miltenyi Biotec CliniMACS, Systemic chemotherapy and antibodies |
| Enrollment | 25 |
| Start date | Jun 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Feb 1, 2009 |
| First posted | Sep 5, 2005 |
| Last update posted | Feb 13, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: